Lady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote Ste-Catherine Road, Montreal, Quebec H3T1E4, Canada.
Department of Health Behavior and Health Systems, School of Public Health, University of North Texas Health Science Center, 3500 Camp Bowie, Blvd., EAD 709M, Fort Worth, TX 76107-2699, USA.
Prev Med. 2018 Nov;116:40-50. doi: 10.1016/j.ypmed.2018.08.034. Epub 2018 Aug 31.
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards implementation of an HPV-DNA test, which is more sensitive than Pap cytology in detecting high-risk lesions and offers greater protection against invasive cervical carcinomas. Based on these results, many countries are recommending and implementing HPV testing-based screening programs. Understanding what factors (e.g., knowledge, attitudes) will impact on HPV test acceptability by women is crucial for ensuring adequate public health practices to optimize cervical screening uptake. We used mixed methods research synthesis to provide a categorization of the relevant factors related to HPV primary screening for cervical cancer and describe their influence on women's acceptability of HPV testing. We searched Medline, Embase, PsycINFO, CINAHL, Global Health and Web of Science for journal articles between January 1, 1980 and October 31, 2017 and retained 22 empirical articles. Our results show that while most factors associated with HPV test acceptability are included in the Health Belief Model and/or Theory of Planned Behavior (e.g., attitudes, knowledge), other important factors are not encompassed by these theoretical frameworks (e.g., health behaviors, negative emotional reactions related to HPV testing). The direction of influence of psychosocial factors on HPV test acceptability was synthesized based on 14 quantitative studies as: facilitators (e.g., high perceived HPV test benefits), barriers (e.g., negative attitudes towards increased screening intervals), contradictory evidence (e.g., sexual history) and no impact (e.g., high perceived severity of HPV infection). Further population-based studies are needed to confirm the impact of these factors on HPV-based screening acceptability.
宫颈癌的初步筛查正从传统的巴氏涂片检查向 HPV-DNA 检测转变,后者在检测高危病变方面比巴氏细胞学检查更敏感,并能更好地预防宫颈癌。基于这些结果,许多国家正在推荐和实施基于 HPV 检测的筛查计划。了解哪些因素(例如知识、态度)将影响女性对 HPV 检测的可接受性,对于确保采取适当的公共卫生措施来优化宫颈癌筛查的参与率至关重要。我们使用混合方法研究综合方法,对与宫颈癌 HPV 初筛相关的相关因素进行分类,并描述它们对女性接受 HPV 检测的影响。我们在 Medline、Embase、PsycINFO、CINAHL、全球健康和 Web of Science 上搜索了 1980 年 1 月 1 日至 2017 年 10 月 31 日之间的期刊文章,并保留了 22 篇实证文章。研究结果表明,尽管与 HPV 检测可接受性相关的大多数因素都包含在健康信念模型和/或计划行为理论中(例如态度、知识),但其他重要因素并不包含在这些理论框架中(例如健康行为、与 HPV 检测相关的负面情绪反应)。根据 14 项定量研究,我们综合了心理社会因素对 HPV 检测可接受性的影响方向,包括促进因素(例如,高认知 HPV 检测益处)、障碍(例如,对增加筛查间隔的负面态度)、矛盾证据(例如,性史)和无影响(例如,高认知 HPV 感染的严重程度)。需要进一步进行基于人群的研究来证实这些因素对 HPV 筛查可接受性的影响。